Celecoxib - Antiarthritic treatment of adenomatous polyposis COX-2 inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of celecoxib, a specific COX-2 inhibitor in patients with rheumatoid arthritis
    Geis, GS
    Hubbard, RC
    Callison, DA
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S70 - S70
  • [42] Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH
    Wang, Jiping
    Cho, Nancy L.
    Zauber, Ann G.
    Hsu, Meier
    Dawson, Dawn
    Srivastava, Amitabh
    Mitchell-Richards, Kisha A.
    Markowitz, Sanford D.
    Bertagnolli, Monica M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 728 - 736
  • [43] COX-2 inhibitor
    Gotzsche, P. C.
    Bjarnasoni, N. H.
    RHEUMATOLOGY, 2007, 46 (10) : 1623 - 1624
  • [44] The effect of celecoxib on duodenal polyposis in familial adenomatous polyposis (FAP).
    Phillips, RK
    Wallace, M
    Lynch, PM
    Hawk, E
    Gordon, GB
    Saunders, BP
    Godio, L
    Rodriguez-Bigas, MA
    Sherman, JW
    Kelloff, G
    Levin, B
    Steinbach, G
    GASTROENTEROLOGY, 2000, 118 (04) : A252 - A252
  • [45] A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
    Phillips, RKS
    Wallace, MH
    Lynch, PM
    Hawk, E
    Gordon, GB
    Saunders, BP
    Wakabayashi, N
    Shen, Y
    Zimmerman, S
    Godio, L
    Rodrigues-Bigas, M
    Su, LK
    Sherman, J
    Kelloff, G
    Levin, B
    Steinbach, G
    GUT, 2002, 50 (06) : 857 - 860
  • [46] Expression of COX-2 and p53 in juvenile polyposis coli and its correlation with adenomatous changes
    Das Gupta, Shatavisha
    Das, Ram Narayan
    Ghosh, Ranajoy
    Sen, Anway
    Chatterjee, Uttara
    Saha, Kaushik
    Datta, Chhanda
    Mishra, Prafulla Kumar
    Bandyopadhyay, Ranjana
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 359 - 363
  • [47] Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam
    Dobbie, Z
    Muller, PY
    Heinimann, K
    Albrecht, C
    D'Orazio, D
    Bendik, I
    Müller, H
    Bauerfeind, P
    ANTICANCER RESEARCH, 2002, 22 (04) : 2215 - 2220
  • [48] Retinoic acid inhibits β-catenin through suppression of Cox-2 -: A role for truncated adenomatous polyposis coli
    Eisinger, Annie L.
    Nadauld, Lincoln D.
    Shelton, Dawne N.
    Prescott, Stephen M.
    Stafforini, Diana M.
    Jones, David A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (40) : 29394 - 29400
  • [49] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Bocca, Claudia
    Bozzo, Francesca
    Bassignana, Andrea
    Miglietta, Antonella
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 350 (1-2) : 59 - 70
  • [50] The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats
    Khayyal M.T.
    El-Ghazaly M.A.
    El-Hazek R.M.
    Nada A.S.
    Inflammopharmacology, 2009, 17 (5) : 255 - 266
12345